Cargando…

Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease

Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias after fetal dopaminergic tissue transplantation. All had levodopa-induc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greene, Paul E., Fahn, Stanley, Eidelberg, David, Bjugstad, Kimberly B., Breeze, Robert E., Freed, Curt R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065148/ https://www.ncbi.nlm.nih.gov/pubmed/33893319 http://dx.doi.org/10.1038/s41531-021-00183-w

Ejemplares similares

Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open‐label ADS‐5102
por: Isaacson, Stuart H., et al.
Publicado: (2018)

Introducing a new journal on Parkinson’s disease
por: Sulzer, David, et al.
Publicado: (2015)

Hydrogel formulation determines cell fate of fetal and adult neural progenitor cells
por: Aurand, Emily R., et al.
Publicado: (2013)

Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia
por: Tronci, Elisabetta, et al.
Publicado: (2015)

PESISTENT PARKINSONISM AND TARDIVE DYSKINESIA
por: Shaji, K.S., et al.
Publicado: (1995)

Dyskinesia in Parkinson's Disease Therapy
por: Carta, Anna Rosa, et al.
Publicado: (2012)

Attempted Reconstruction of the Cortico-Striatal Pathway Using Fetal Cortical Tissue Transplants
por: Herranz, A. S., et al.
Publicado: (1992)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
por: Piedad, John C. P., et al.
Publicado: (2012)

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
por: Pahwa, Rajesh, et al.
Publicado: (2022)

A Retrospective Look at Recent COVID-19 Articles Published in Cell Transplantation: Research Leading to Further Understanding
por: Sanberg, Paul, et al.
Publicado: (2021)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
por: Bektaş, Hesna, et al.
Publicado: (2014)

Parkinson’s disease: carbidopa, nausea, and dyskinesia
por: Hinz, Marty, et al.
Publicado: (2014)

Surgical Treatment of Dyskinesia in Parkinson’s Disease
por: Munhoz, Renato P., et al.
Publicado: (2014)

Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease
por: Athulya, RT, et al.
Publicado: (2020)

Building Biocompatible Hydrogels for Tissue Engineering of the Brain and Spinal Cord
por: Aurand, Emily R., et al.
Publicado: (2012)

Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease
por: Zecca, Luigi, et al.
Publicado: (2021)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Publicado: (2021)

Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?
por: Politis, Marios
Publicado: (2010)

A(2A) Receptor Antagonism and Dyskinesia in Parkinson's Disease
por: Morelli, Micaela, et al.
Publicado: (2012)

Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2021)

Parkinson’s disease progression: Increasing expression of an invariant common core subnetwork
por: Spetsieris, Phoebe G., et al.
Publicado: (2023)

Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson’s disease
por: Spetsieris, Phoebe G., et al.
Publicado: (2020)

Fetal Tissue Transplants in Medicine
por: Loo, Dana
Publicado: (1993)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas, Panagiotis, et al.
Publicado: (2013)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
por: Krishnan, Syam, et al.
Publicado: (2017)

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China
por: Zhou, Xun, et al.
Publicado: (2019)

Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
por: Yoo, Han Soo, et al.
Publicado: (2019)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
Publicado: (2020)

ASNTR’s Venture into a Hybrid Conference: Lessons Learned During the COVID-19 Pandemic
por: Sanberg, Paul, et al.
Publicado: (2021)

Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)
por: Pahwa, Rajesh, et al.
Publicado: (2015)

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson’s disease
por: Sharma, Vibhash D, et al.
Publicado: (2018)

Neurosurgical Treatment of Parkinsonism and Allied Disorders of Involuntary Movement (Dyskinesiæ)
por: Gordon, Derek S.
Publicado: (1959)

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
por: Sawada, Hideyuki, et al.
Publicado: (2010)

The acute brain response to levodopa heralds dyskinesias in Parkinson disease
por: Herz, Damian M., et al.
Publicado: (2014)

An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease
por: Kong, Min, et al.
Publicado: (2017)

Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
por: Wang, Miao, et al.
Publicado: (2021)

Disentangling dyskinesia from parkinsonism in motor structures of patients with schizophrenia
por: Sakreida, Katrin, et al.
Publicado: (2022)

High PSQI score is associated with the development of dyskinesia in Parkinson’s disease
por: Tang, Xiaohui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jpmn1p3f5hui269tllo5mq6m1k